In conclusion, our study demonstrates that TXNRD1 is a promising candidate biomarker for diagnosis of IPAH and plays an important role in PAH pathogenesis, although further research is necessary. The gene discussed is TXNRD1; the disease is pulmonary arterial hypertension.